digital health investing
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.
The company's valuation has increased by $1 billion since its $130 million Series E funding round last year.
The San Francisco-based telemental health company will use funds to grow into new markets.
Investors are no longer meeting new partners face to face, but primed funds and new demand for converging digital products still fuel new deals.
Bryan Roberts
Bryan Roberts, one of Venrock's healthcare-focused investment partners, has some rules of thumb for investing in digital health -- and for what to pass up.